Glucose Monitoring Devices Market By Device (Blood Glucose Meters, Continuous Glucose Monitoring Systems, Flash Glucose Monitoring Systems, Smartphone Apps and Wearables), By Patient Type (Type 1 Diabetes, Type 2 Diabetes) By End User (Hospitals and Clini

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $5,820	216 Pages	Allied Market Research	July, 2024	ALMR19230250

Best Price Guarantee
Price	from $5,820
Length	216 Pages
Publisher	Allied Market Research
Published Date	July, 2024
SKU	ALMR19230250

Glucose Monitoring Devices Market By Device (Blood Glucose Meters, Continuous Glucose Monitoring Systems, Flash Glucose Monitoring Systems, Smartphone Apps and Wearables), By Patient Type (Type 1 Diabetes, Type 2 Diabetes) By End User (Hospitals and Clinics, Home Care Settings, Others) : Global Opportunity Analysis and Industry Forecast, 2024-2033

Glucose Monitoring Devices Market
The glucose monitoring devices market was valued at $14.7 billion in 2023 and is projected to reach $38.9 billion by 2033, growing at a CAGR of 10.2% from 2024 to 2033.
Glucose monitoring involves the measuring and tracking the glucose levels in the blood or interstitial fluid of individuals. It is an essential routine for individuals with diabetes for effective management, as it provides data about fluctuations in blood sugar levels throughout the day in response to several factors such as food intake, stress, physical activity, and medication. The real-time or periodic glucose readings provided glucose monitoring devices allow individuals to make informed decisions regarding dietary choices, medication dosage, and lifestyle adjustments. Glucose monitoring devices are critical equipment for the prevention of short-term and long-term complications associated with diabetes.
Increase in prevalence of lifestyle diseases, including obesity and diabetes, is a major driver of the glucose monitoring devices market. In addition, the demand for self-monitoring portable devices is surging among individuals, hence augmenting the development of the market. Non-invasive glucose monitoring devices are trending in the market currently. Optical sensors and microneedle patches are among the most common equipment available in the market. Furthermore, the integration of data analytics is acquiring traction from individuals and healthcare providers as it aids to identify patterns and trends, thereby assisting in proactive management and prevention of diseases.
However, a large base of individuals adheres to the traditional method of glucose testing owing to high confidence in its results, which presents challenges for the widespread adoption of new & innovative glucose monitoring devices. Moreover, the approval process of new monitoring devices is highly stringent and lengthy, which often delays the introduction of novel products into the market. Contrarily, the constant efforts of scientists to launch innovative products present lucrative opportunities for the expansion of the market. For instance, researchers of the King Abdullah University of Science & Technology, Saudi Arabia developed a prototype for a sensor that measures glucose levels using saliva. This device is projected to be a simple, quick, and painless way for individuals to measure blood glucose in the future.

Segment Review

The glucose monitoring devices market is segmented into device, patient type, end user, and region. On the basis of device, the market is divided into blood glucose meters, continuous glucose monitoring systems, flash glucose monitoring systems, smartphone apps, and wearables. By patient type, it is bifurcated into type 1 diabetes and type 2 diabetes. According to end user, it is classified into hospitals & clinics, home care settings, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

On the basis of device, the continuous glucose monitoring devices segment generated the highest revenue in the market in 2023.
By patient type, the type 1 diabetes segment was the highest shareholder in 2023.
According to end user, the home care settings segment was the highest revenue generator in 2023.

Competition Analysis

The major players operating in the global glucose monitoring devices market include Menarini Diagnostics S.R.L., Senseonics, A., Novo Nordisk A/S, GlySens Incorporated, Johnson & Johnson, DexCom, Inc., Medtronic plc, F. Hoffman-La Roche Ltd, Abbott laboratories, and B. Braun SE. These players have adopted various key developmental strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the market.

Key Market Segments

By Device

Blood Glucose Meters
Continuous Glucose Monitoring Systems
Flash Glucose Monitoring Systems
Smartphone Apps and Wearables

By Patient Type

Type 1 Diabetes
Type 2 Diabetes

By End User

Hospitals and Clinics
Home Care Settings
Others

By Region

North America
U.S.
Canada
Mexico
Europe
France
Germany
Italy
Spain
UK
Rest of Europe
Asia-Pacific
China
Japan
India
South Korea
Australia
Rest of Asia-Pacific
LAMEA
Brazil
South Africa
Saudi Arabia
Rest of LAMEA
Key Market Players
Menarini Diagnostics S.R.L.
Senseonics, A.
Novo Nordisk A/S
GlySens Incorporated
Johnson & Johnson
DexCom, Inc.
Medtronic plc
F. Hoffman-La Roche Ltd
Abbott laboratories
B. Braun SE

CHAPTER 1: INTRODUCTION: 1.1. Report Description; 1.2. Key Market Segments; 1.3. Key Benefits; 1.4. Research Methodology; 1.4.1. Primary Research; 1.4.2. Secondary Research; 1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY: 2.1. CXO Perspective
CHAPTER 3: MARKET LANDSCAPE: 3.1. Market Definition and Scope; 3.2. Key Findings; 3.2.1. Top Investment Pockets; 3.2.2. Top Winning Strategies; 3.3. Porter's Five Forces Analysis; 3.3.1. Bargaining Power of Suppliers; 3.3.2. Threat of New Entrants; 3.3.3. Threat of Substitutes; 3.3.4. Competitive Rivalry; 3.3.5. Bargaining Power among Buyers; 3.5. Market Dynamics; 3.5.1. Drivers; 3.5.2. Restraints; 3.5.3. Opportunities
CHAPTER 4: GLUCOSE MONITORING DEVICES MARKET, BY DEVICE: 4.1. Market Overview; 4.1.1 Market Size and Forecast, By Device; 4.2. Blood Glucose Meters; 4.2.1. Key Market Trends, Growth Factors and Opportunities; 4.2.2. Market Size and Forecast, By Region; 4.2.3. Market Share Analysis, By Country; 4.3. Continuous Glucose Monitoring Systems; 4.3.1. Key Market Trends, Growth Factors and Opportunities; 4.3.2. Market Size and Forecast, By Region; 4.3.3. Market Share Analysis, By Country; 4.4. Flash Glucose Monitoring Systems; 4.4.1. Key Market Trends, Growth Factors and Opportunities; 4.4.2. Market Size and Forecast, By Region; 4.4.3. Market Share Analysis, By Country; 4.5. Smartphone Apps And Wearables; 4.5.1. Key Market Trends, Growth Factors and Opportunities; 4.5.2. Market Size and Forecast, By Region; 4.5.3. Market Share Analysis, By Country
CHAPTER 5: GLUCOSE MONITORING DEVICES MARKET, BY PATIENT TYPE: 5.1. Market Overview; 5.1.1 Market Size and Forecast, By Patient Type; 5.2. Type 1 Diabetes; 5.2.1. Key Market Trends, Growth Factors and Opportunities; 5.2.2. Market Size and Forecast, By Region; 5.2.3. Market Share Analysis, By Country; 5.3. Type 2 Diabetes; 5.3.1. Key Market Trends, Growth Factors and Opportunities; 5.3.2. Market Size and Forecast, By Region; 5.3.3. Market Share Analysis, By Country
CHAPTER 6: GLUCOSE MONITORING DEVICES MARKET, BY END USER: 6.1. Market Overview; 6.1.1 Market Size and Forecast, By End User; 6.2. Hospitals And Clinics; 6.2.1. Key Market Trends, Growth Factors and Opportunities; 6.2.2. Market Size and Forecast, By Region; 6.2.3. Market Share Analysis, By Country; 6.3. Home Care Settings; 6.3.1. Key Market Trends, Growth Factors and Opportunities; 6.3.2. Market Size and Forecast, By Region; 6.3.3. Market Share Analysis, By Country; 6.4. Others; 6.4.1. Key Market Trends, Growth Factors and Opportunities; 6.4.2. Market Size and Forecast, By Region; 6.4.3. Market Share Analysis, By Country
CHAPTER 7: GLUCOSE MONITORING DEVICES MARKET, BY REGION: 7.1. Market Overview; 7.1.1 Market Size and Forecast, By Region; 7.2. North America; 7.2.1. Key Market Trends and Opportunities; 7.2.2. Market Size and Forecast, By Device; 7.2.3. Market Size and Forecast, By Patient Type; 7.2.4. Market Size and Forecast, By End User; 7.2.5. Market Size and Forecast, By Country; 7.2.6. U.S. Glucose Monitoring Devices Market; 7.2.6.1. Market Size and Forecast, By Device; 7.2.6.2. Market Size and Forecast, By Patient Type; 7.2.6.3. Market Size and Forecast, By End User; 7.2.7. Canada Glucose Monitoring Devices Market; 7.2.7.1. Market Size and Forecast, By Device; 7.2.7.2. Market Size and Forecast, By Patient Type; 7.2.7.3. Market Size and Forecast, By End User; 7.2.8. Mexico Glucose Monitoring Devices Market; 7.2.8.1. Market Size and Forecast, By Device; 7.2.8.2. Market Size and Forecast, By Patient Type; 7.2.8.3. Market Size and Forecast, By End User; 7.3. Europe; 7.3.1. Key Market Trends and Opportunities; 7.3.2. Market Size and Forecast, By Device; 7.3.3. Market Size and Forecast, By Patient Type; 7.3.4. Market Size and Forecast, By End User; 7.3.5. Market Size and Forecast, By Country; 7.3.6. France Glucose Monitoring Devices Market; 7.3.6.1. Market Size and Forecast, By Device; 7.3.6.2. Market Size and Forecast, By Patient Type; 7.3.6.3. Market Size and Forecast, By End User; 7.3.7. Germany Glucose Monitoring Devices Market; 7.3.7.1. Market Size and Forecast, By Device; 7.3.7.2. Market Size and Forecast, By Patient Type; 7.3.7.3. Market Size and Forecast, By End User; 7.3.8. Italy Glucose Monitoring Devices Market; 7.3.8.1. Market Size and Forecast, By Device; 7.3.8.2. Market Size and Forecast, By Patient Type; 7.3.8.3. Market Size and Forecast, By End User; 7.3.9. Spain Glucose Monitoring Devices Market; 7.3.9.1. Market Size and Forecast, By Device; 7.3.9.2. Market Size and Forecast, By Patient Type; 7.3.9.3. Market Size and Forecast, By End User; 7.3.10. UK Glucose Monitoring Devices Market; 7.3.10.1. Market Size and Forecast, By Device; 7.3.10.2. Market Size and Forecast, By Patient Type; 7.3.10.3. Market Size and Forecast, By End User; 7.3.11. Rest Of Europe Glucose Monitoring Devices Market; 7.3.11.1. Market Size and Forecast, By Device; 7.3.11.2. Market Size and Forecast, By Patient Type; 7.3.11.3. Market Size and Forecast, By End User; 7.4. Asia-Pacific; 7.4.1. Key Market Trends and Opportunities; 7.4.2. Market Size and Forecast, By Device; 7.4.3. Market Size and Forecast, By Patient Type; 7.4.4. Market Size and Forecast, By End User; 7.4.5. Market Size and Forecast, By Country; 7.4.6. China Glucose Monitoring Devices Market; 7.4.6.1. Market Size and Forecast, By Device; 7.4.6.2. Market Size and Forecast, By Patient Type; 7.4.6.3. Market Size and Forecast, By End User; 7.4.7. Japan Glucose Monitoring Devices Market; 7.4.7.1. Market Size and Forecast, By Device; 7.4.7.2. Market Size and Forecast, By Patient Type; 7.4.7.3. Market Size and Forecast, By End User; 7.4.8. India Glucose Monitoring Devices Market; 7.4.8.1. Market Size and Forecast, By Device; 7.4.8.2. Market Size and Forecast, By Patient Type; 7.4.8.3. Market Size and Forecast, By End User; 7.4.9. South Korea Glucose Monitoring Devices Market; 7.4.9.1. Market Size and Forecast, By Device; 7.4.9.2. Market Size and Forecast, By Patient Type; 7.4.9.3. Market Size and Forecast, By End User; 7.4.10. Australia Glucose Monitoring Devices Market; 7.4.10.1. Market Size and Forecast, By Device; 7.4.10.2. Market Size and Forecast, By Patient Type; 7.4.10.3. Market Size and Forecast, By End User; 7.4.11. Rest of Asia-Pacific Glucose Monitoring Devices Market; 7.4.11.1. Market Size and Forecast, By Device; 7.4.11.2. Market Size and Forecast, By Patient Type; 7.4.11.3. Market Size and Forecast, By End User; 7.5. LAMEA; 7.5.1. Key Market Trends and Opportunities; 7.5.2. Market Size and Forecast, By Device; 7.5.3. Market Size and Forecast, By Patient Type; 7.5.4. Market Size and Forecast, By End User; 7.5.5. Market Size and Forecast, By Country; 7.5.6. Brazil Glucose Monitoring Devices Market; 7.5.6.1. Market Size and Forecast, By Device; 7.5.6.2. Market Size and Forecast, By Patient Type; 7.5.6.3. Market Size and Forecast, By End User; 7.5.7. South Africa Glucose Monitoring Devices Market; 7.5.7.1. Market Size and Forecast, By Device; 7.5.7.2. Market Size and Forecast, By Patient Type; 7.5.7.3. Market Size and Forecast, By End User; 7.5.8. Saudi Arabia Glucose Monitoring Devices Market; 7.5.8.1. Market Size and Forecast, By Device; 7.5.8.2. Market Size and Forecast, By Patient Type; 7.5.8.3. Market Size and Forecast, By End User; 7.5.9. Rest of LAMEA Glucose Monitoring Devices Market; 7.5.9.1. Market Size and Forecast, By Device; 7.5.9.2. Market Size and Forecast, By Patient Type; 7.5.9.3. Market Size and Forecast, By End User
CHAPTER 8: COMPETITIVE LANDSCAPE: 8.1. Introduction; 8.2. Top Winning Strategies; 8.3. Product Mapping Of Top 10 Player; 8.4. Competitive Dashboard; 8.5. Competitive Heatmap; 8.6. Top Player Positioning, 2023
CHAPTER 9: COMPANY PROFILES: 9.1. Menarini Diagnostics S.R.L.; 9.1.1. Company Overview; 9.1.2. Key Executives; 9.1.3. Company Snapshot; 9.1.4. Operating Business Segments; 9.1.5. Product Portfolio; 9.1.6. Business Performance; 9.1.7. Key Strategic Moves and Developments; 9.2. Senseonics, A.; 9.2.1. Company Overview; 9.2.2. Key Executives; 9.2.3. Company Snapshot; 9.2.4. Operating Business Segments; 9.2.5. Product Portfolio; 9.2.6. Business Performance; 9.2.7. Key Strategic Moves and Developments; 9.3. Novo Nordisk A/S; 9.3.1. Company Overview; 9.3.2. Key Executives; 9.3.3. Company Snapshot; 9.3.4. Operating Business Segments; 9.3.5. Product Portfolio; 9.3.6. Business Performance; 9.3.7. Key Strategic Moves and Developments; 9.4. GlySens Incorporated; 9.4.1. Company Overview; 9.4.2. Key Executives; 9.4.3. Company Snapshot; 9.4.4. Operating Business Segments; 9.4.5. Product Portfolio; 9.4.6. Business Performance; 9.4.7. Key Strategic Moves and Developments; 9.5. Johnson And Johnson; 9.5.1. Company Overview; 9.5.2. Key Executives; 9.5.3. Company Snapshot; 9.5.4. Operating Business Segments; 9.5.5. Product Portfolio; 9.5.6. Business Performance; 9.5.7. Key Strategic Moves and Developments; 9.6. DexCom, Inc.; 9.6.1. Company Overview; 9.6.2. Key Executives; 9.6.3. Company Snapshot; 9.6.4. Operating Business Segments; 9.6.5. Product Portfolio; 9.6.6. Business Performance; 9.6.7. Key Strategic Moves and Developments; 9.7. Medtronic Plc; 9.7.1. Company Overview; 9.7.2. Key Executives; 9.7.3. Company Snapshot; 9.7.4. Operating Business Segments; 9.7.5. Product Portfolio; 9.7.6. Business Performance; 9.7.7. Key Strategic Moves and Developments; 9.8. F. Hoffman-La Roche Ltd; 9.8.1. Company Overview; 9.8.2. Key Executives; 9.8.3. Company Snapshot; 9.8.4. Operating Business Segments; 9.8.5. Product Portfolio; 9.8.6. Business Performance; 9.8.7. Key Strategic Moves and Developments; 9.9. Abbott Laboratories; 9.9.1. Company Overview; 9.9.2. Key Executives; 9.9.3. Company Snapshot; 9.9.4. Operating Business Segments; 9.9.5. Product Portfolio; 9.9.6. Business Performance; 9.9.7. Key Strategic Moves and Developments; 9.10. B. Braun SE; 9.10.1. Company Overview; 9.10.2. Key Executives; 9.10.3. Company Snapshot; 9.10.4. Operating Business Segments; 9.10.5. Product Portfolio; 9.10.6. Business Performance; 9.10.7. Key Strategic Moves and Developments; TABLE 1. GLOBAL GLUCOSE MONITORING DEVICES MARKET, BY DEVICE, 2024 - 2033 ($BILLION); TABLE 2. GLUCOSE MONITORING DEVICES MARKET FOR BLOOD GLUCOSE METERS, BY REGION, 2024 - 2033 ($BILLION); TABLE 3. GLUCOSE MONITORING DEVICES MARKET FOR CONTINUOUS GLUCOSE MONITORING SYSTEMS, BY REGION, 2024 - 2033 ($BILLION); TABLE 4. GLUCOSE MONITORING DEVICES MARKET FOR FLASH GLUCOSE MONITORING SYSTEMS, BY REGION, 2024 - 2033 ($BILLION); TABLE 5. GLUCOSE MONITORING DEVICES MARKET FOR SMARTPHONE APPS AND WEARABLES, BY REGION, 2024 - 2033 ($BILLION); TABLE 6. GLOBAL GLUCOSE MONITORING DEVICES MARKET, BY PATIENT TYPE, 2024 - 2033 ($BILLION); TABLE 7. GLUCOSE MONITORING DEVICES MARKET FOR TYPE 1 DIABETES, BY REGION, 2024 - 2033 ($BILLION); TABLE 8. GLUCOSE MONITORING DEVICES MARKET FOR TYPE 2 DIABETES, BY REGION, 2024 - 2033 ($BILLION); TABLE 9. GLOBAL GLUCOSE MONITORING DEVICES MARKET, BY END USER, 2024 - 2033 ($BILLION); TABLE 10. GLUCOSE MONITORING DEVICES MARKET FOR HOSPITALS AND CLINICS, BY REGION, 2024 - 2033 ($BILLION); TABLE 11. GLUCOSE MONITORING DEVICES MARKET FOR HOME CARE SETTINGS, BY REGION, 2024 - 2033 ($BILLION); TABLE 12. GLUCOSE MONITORING DEVICES MARKET FOR OTHERS, BY REGION, 2024 - 2033 ($BILLION); TABLE 13. GLUCOSE MONITORING DEVICES MARKET, BY REGION, 2024 - 2033 ($BILLION); TABLE 14. NORTH AMERICA GLUCOSE MONITORING DEVICES, BY COUNTRY, 2024 - 2033 ($BILLION); TABLE 15. NORTH AMERICA GLUCOSE MONITORING DEVICES, BY DEVICE, 2024 - 2033 ($BILLION); TABLE 16. NORTH AMERICA GLUCOSE MONITORING DEVICES, BY PATIENT TYPE, 2024 - 2033 ($BILLION); TABLE 17. NORTH AMERICA GLUCOSE MONITORING DEVICES, BY END USER, 2024 - 2033 ($BILLION); TABLE 18. U.S. GLUCOSE MONITORING DEVICES, BY DEVICE, 2024 - 2033 ($BILLION); TABLE 19. U.S. GLUCOSE MONITORING DEVICES, BY PATIENT TYPE, 2024 - 2033 ($BILLION); TABLE 20. U.S. GLUCOSE MONITORING DEVICES, BY END USER, 2024 - 2033 ($BILLION); TABLE 21. CANADA GLUCOSE MONITORING DEVICES, BY DEVICE, 2024 - 2033 ($BILLION); TABLE 22. CANADA GLUCOSE MONITORING DEVICES, BY PATIENT TYPE, 2024 - 2033 ($BILLION); TABLE 23. CANADA GLUCOSE MONITORING DEVICES, BY END USER, 2024 - 2033 ($BILLION); TABLE 24. MEXICO GLUCOSE MONITORING DEVICES, BY DEVICE, 2024 - 2033 ($BILLION); TABLE 25. MEXICO GLUCOSE MONITORING DEVICES, BY PATIENT TYPE, 2024 - 2033 ($BILLION); TABLE 26. MEXICO GLUCOSE MONITORING DEVICES, BY END USER, 2024 - 2033 ($BILLION); TABLE 27. EUROPE GLUCOSE MONITORING DEVICES, BY COUNTRY, 2024 - 2033 ($BILLION); TABLE 28. EUROPE GLUCOSE MONITORING DEVICES, BY DEVICE, 2024 - 2033 ($BILLION); TABLE 29. EUROPE GLUCOSE MONITORING DEVICES, BY PATIENT TYPE, 2024 - 2033 ($BILLION); TABLE 30. EUROPE GLUCOSE MONITORING DEVICES, BY END USER, 2024 - 2033 ($BILLION); TABLE 31. FRANCE GLUCOSE MONITORING DEVICES, BY DEVICE, 2024 - 2033 ($BILLION); TABLE 32. FRANCE GLUCOSE MONITORING DEVICES, BY PATIENT TYPE, 2024 - 2033 ($BILLION); TABLE 33. FRANCE GLUCOSE MONITORING DEVICES, BY END USER, 2024 - 2033 ($BILLION); TABLE 34. GERMANY GLUCOSE MONITORING DEVICES, BY DEVICE, 2024 - 2033 ($BILLION); TABLE 35. GERMANY GLUCOSE MONITORING DEVICES, BY PATIENT TYPE, 2024 - 2033 ($BILLION); TABLE 36. GERMANY GLUCOSE MONITORING DEVICES, BY END USER, 2024 - 2033 ($BILLION); TABLE 37. ITALY GLUCOSE MONITORING DEVICES, BY DEVICE, 2024 - 2033 ($BILLION); TABLE 38. ITALY GLUCOSE MONITORING DEVICES, BY PATIENT TYPE, 2024 - 2033 ($BILLION); TABLE 39. ITALY GLUCOSE MONITORING DEVICES, BY END USER, 2024 - 2033 ($BILLION); TABLE 40. SPAIN GLUCOSE MONITORING DEVICES, BY DEVICE, 2024 - 2033 ($BILLION); TABLE 41. SPAIN GLUCOSE MONITORING DEVICES, BY PATIENT TYPE, 2024 - 2033 ($BILLION); TABLE 42. SPAIN GLUCOSE MONITORING DEVICES, BY END USER, 2024 - 2033 ($BILLION); TABLE 43. UK GLUCOSE MONITORING DEVICES, BY DEVICE, 2024 - 2033 ($BILLION); TABLE 44. UK GLUCOSE MONITORING DEVICES, BY PATIENT TYPE, 2024 - 2033 ($BILLION); TABLE 45. UK GLUCOSE MONITORING DEVICES, BY END USER, 2024 - 2033 ($BILLION); TABLE 46. REST OF EUROPE GLUCOSE MONITORING DEVICES, BY DEVICE, 2024 - 2033 ($BILLION); TABLE 47. REST OF EUROPE GLUCOSE MONITORING DEVICES, BY PATIENT TYPE, 2024 - 2033 ($BILLION); TABLE 48. REST OF EUROPE GLUCOSE MONITORING DEVICES, BY END USER, 2024 - 2033 ($BILLION); TABLE 49. ASIA-PACIFIC GLUCOSE MONITORING DEVICES, BY COUNTRY, 2024 - 2033 ($BILLION); TABLE 50. ASIA-PACIFIC GLUCOSE MONITORING DEVICES, BY DEVICE, 2024 - 2033 ($BILLION); TABLE 51. ASIA-PACIFIC GLUCOSE MONITORING DEVICES, BY PATIENT TYPE, 2024 - 2033 ($BILLION); TABLE 52. ASIA-PACIFIC GLUCOSE MONITORING DEVICES, BY END USER, 2024 - 2033 ($BILLION); TABLE 53. CHINA GLUCOSE MONITORING DEVICES, BY DEVICE, 2024 - 2033 ($BILLION); TABLE 54. CHINA GLUCOSE MONITORING DEVICES, BY PATIENT TYPE, 2024 - 2033 ($BILLION); TABLE 55. CHINA GLUCOSE MONITORING DEVICES, BY END USER, 2024 - 2033 ($BILLION); TABLE 56. JAPAN GLUCOSE MONITORING DEVICES, BY DEVICE, 2024 - 2033 ($BILLION); TABLE 57. JAPAN GLUCOSE MONITORING DEVICES, BY PATIENT TYPE, 2024 - 2033 ($BILLION); TABLE 58. JAPAN GLUCOSE MONITORING DEVICES, BY END USER, 2024 - 2033 ($BILLION); TABLE 59. INDIA GLUCOSE MONITORING DEVICES, BY DEVICE, 2024 - 2033 ($BILLION); TABLE 60. INDIA GLUCOSE MONITORING DEVICES, BY PATIENT TYPE, 2024 - 2033 ($BILLION); TABLE 61. INDIA GLUCOSE MONITORING DEVICES, BY END USER, 2024 - 2033 ($BILLION); TABLE 62. SOUTH KOREA GLUCOSE MONITORING DEVICES, BY DEVICE, 2024 - 2033 ($BILLION); TABLE 63. SOUTH KOREA GLUCOSE MONITORING DEVICES, BY PATIENT TYPE, 2024 - 2033 ($BILLION); TABLE 64. SOUTH KOREA GLUCOSE MONITORING DEVICES, BY END USER, 2024 - 2033 ($BILLION); TABLE 65. AUSTRALIA GLUCOSE MONITORING DEVICES, BY DEVICE, 2024 - 2033 ($BILLION); TABLE 66. AUSTRALIA GLUCOSE MONITORING DEVICES, BY PATIENT TYPE, 2024 - 2033 ($BILLION); TABLE 67. AUSTRALIA GLUCOSE MONITORING DEVICES, BY END USER, 2024 - 2033 ($BILLION); TABLE 68. REST OF ASIA-PACIFIC GLUCOSE MONITORING DEVICES, BY DEVICE, 2024 - 2033 ($BILLION); TABLE 69. REST OF ASIA-PACIFIC GLUCOSE MONITORING DEVICES, BY PATIENT TYPE, 2024 - 2033 ($BILLION); TABLE 70. REST OF ASIA-PACIFIC GLUCOSE MONITORING DEVICES, BY END USER, 2024 - 2033 ($BILLION); TABLE 71. LAMEA GLUCOSE MONITORING DEVICES, BY COUNTRY, 2024 - 2033 ($BILLION); TABLE 72. LAMEA GLUCOSE MONITORING DEVICES, BY DEVICE, 2024 - 2033 ($BILLION); TABLE 73. LAMEA GLUCOSE MONITORING DEVICES, BY PATIENT TYPE, 2024 - 2033 ($BILLION); TABLE 74. LAMEA GLUCOSE MONITORING DEVICES, BY END USER, 2024 - 2033 ($BILLION); TABLE 75. BRAZIL GLUCOSE MONITORING DEVICES, BY DEVICE, 2024 - 2033 ($BILLION); TABLE 76. BRAZIL GLUCOSE MONITORING DEVICES, BY PATIENT TYPE, 2024 - 2033 ($BILLION); TABLE 77. BRAZIL GLUCOSE MONITORING DEVICES, BY END USER, 2024 - 2033 ($BILLION); TABLE 78. SOUTH AFRICA GLUCOSE MONITORING DEVICES, BY DEVICE, 2024 - 2033 ($BILLION); TABLE 79. SOUTH AFRICA GLUCOSE MONITORING DEVICES, BY PATIENT TYPE, 2024 - 2033 ($BILLION); TABLE 80. SOUTH AFRICA GLUCOSE MONITORING DEVICES, BY END USER, 2024 - 2033 ($BILLION); TABLE 81. SAUDI ARABIA GLUCOSE MONITORING DEVICES, BY DEVICE, 2024 - 2033 ($BILLION); TABLE 82. SAUDI ARABIA GLUCOSE MONITORING DEVICES, BY PATIENT TYPE, 2024 - 2033 ($BILLION); TABLE 83. SAUDI ARABIA GLUCOSE MONITORING DEVICES, BY END USER, 2024 - 2033 ($BILLION); TABLE 84. REST OF LAMEA GLUCOSE MONITORING DEVICES, BY DEVICE, 2024 - 2033 ($BILLION); TABLE 85. REST OF LAMEA GLUCOSE MONITORING DEVICES, BY PATIENT TYPE, 2024 - 2033 ($BILLION); TABLE 86. REST OF LAMEA GLUCOSE MONITORING DEVICES, BY END USER, 2024 - 2033 ($BILLION); TABLE 87. MENARINI DIAGNOSTICS S.R.L.: KEY EXECUTIVES; TABLE 88. MENARINI DIAGNOSTICS S.R.L.: COMPANY SNAPSHOT; TABLE 89. MENARINI DIAGNOSTICS S.R.L.: OPERATING SEGMENTS; TABLE 90. MENARINI DIAGNOSTICS S.R.L.: PRODUCT PORTFOLIO; TABLE 91. MENARINI DIAGNOSTICS S.R.L.: KEY STRATEGIC MOVES AND DEVELOPMENTS; TABLE 92. SENSEONICS, A.: KEY EXECUTIVES; TABLE 93. SENSEONICS, A.: COMPANY SNAPSHOT; TABLE 94. SENSEONICS, A.: OPERATING SEGMENTS; TABLE 95. SENSEONICS, A.: PRODUCT PORTFOLIO; TABLE 96. SENSEONICS, A.: KEY STRATEGIC MOVES AND DEVELOPMENTS; TABLE 97. NOVO NORDISK A/S: KEY EXECUTIVES; TABLE 98. NOVO NORDISK A/S: COMPANY SNAPSHOT; TABLE 99. NOVO NORDISK A/S: OPERATING SEGMENTS; TABLE 100. NOVO NORDISK A/S: PRODUCT PORTFOLIO; TABLE 101. NOVO NORDISK A/S: KEY STRATEGIC MOVES AND DEVELOPMENTS; TABLE 102. GLYSENS INCORPORATED: KEY EXECUTIVES; TABLE 103. GLYSENS INCORPORATED: COMPANY SNAPSHOT; TABLE 104. GLYSENS INCORPORATED: OPERATING SEGMENTS; TABLE 105. GLYSENS INCORPORATED: PRODUCT PORTFOLIO; TABLE 106. GLYSENS INCORPORATED: KEY STRATEGIC MOVES AND DEVELOPMENTS; TABLE 107. JOHNSON AND JOHNSON: KEY EXECUTIVES; TABLE 108. JOHNSON AND JOHNSON: COMPANY SNAPSHOT; TABLE 109. JOHNSON AND JOHNSON: OPERATING SEGMENTS; TABLE 110. JOHNSON AND JOHNSON: PRODUCT PORTFOLIO; TABLE 111. JOHNSON AND JOHNSON: KEY STRATEGIC MOVES AND DEVELOPMENTS; TABLE 112. DEXCOM, INC.: KEY EXECUTIVES; TABLE 113. DEXCOM, INC.: COMPANY SNAPSHOT; TABLE 114. DEXCOM, INC.: OPERATING SEGMENTS; TABLE 115. DEXCOM, INC.: PRODUCT PORTFOLIO; TABLE 116. DEXCOM, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS; TABLE 117. MEDTRONIC PLC: KEY EXECUTIVES; TABLE 118. MEDTRONIC PLC: COMPANY SNAPSHOT; TABLE 119. MEDTRONIC PLC: OPERATING SEGMENTS; TABLE 120. MEDTRONIC PLC: PRODUCT PORTFOLIO; TABLE 121. MEDTRONIC PLC: KEY STRATEGIC MOVES AND DEVELOPMENTS; TABLE 122. F. HOFFMAN-LA ROCHE LTD: KEY EXECUTIVES; TABLE 123. F. HOFFMAN-LA ROCHE LTD: COMPANY SNAPSHOT; TABLE 124. F. HOFFMAN-LA ROCHE LTD: OPERATING SEGMENTS; TABLE 125. F. HOFFMAN-LA ROCHE LTD: PRODUCT PORTFOLIO; TABLE 126. F. HOFFMAN-LA ROCHE LTD: KEY STRATEGIC MOVES AND DEVELOPMENTS; TABLE 127. ABBOTT LABORATORIES: KEY EXECUTIVES; TABLE 128. ABBOTT LABORATORIES: COMPANY SNAPSHOT; TABLE 129. ABBOTT LABORATORIES: OPERATING SEGMENTS; TABLE 130. ABBOTT LABORATORIES: PRODUCT PORTFOLIO; TABLE 131. ABBOTT LABORATORIES: KEY STRATEGIC MOVES AND DEVELOPMENTS; TABLE 132. B. BRAUN SE: KEY EXECUTIVES; TABLE 133. B. BRAUN SE: COMPANY SNAPSHOT; TABLE 134. B. BRAUN SE: OPERATING SEGMENTS; TABLE 135. B. BRAUN SE: PRODUCT PORTFOLIO; TABLE 136. B. BRAUN SE: KEY STRATEGIC MOVES AND DEVELOPMENTS; FIGURE 1. GLOBAL GLUCOSE MONITORING DEVICES MARKET SEGMENTATION; FIGURE 2. GLOBAL GLUCOSE MONITORING DEVICES MARKET; FIGURE 3. SEGMENTATION GLUCOSE MONITORING DEVICES MARKET; FIGURE 4. TOP INVESTMENT POCKET IN GLUCOSE MONITORING DEVICES MARKET; FIGURE 5. MODERATE BARGAINING POWER OF BUYERS; FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS; FIGURE 7. MODERATE THREAT OF NEW ENTRANTS; FIGURE 8. LOW THREAT OF SUBSTITUTION; FIGURE 9. HIGH COMPETITIVE RIVALRY; FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALGLUCOSE MONITORING DEVICES MARKET; FIGURE 11. GLOBAL GLUCOSE MONITORING DEVICES MARKET SEGMENTATION, BY DEVICE; FIGURE 12. GLUCOSE MONITORING DEVICES MARKET FOR BLOOD GLUCOSE METERS, BY COUNTRY, 2024 - 2033 ($BILLION); FIGURE 13. GLUCOSE MONITORING DEVICES MARKET FOR CONTINUOUS GLUCOSE MONITORING SYSTEMS, BY COUNTRY, 2024 - 2033 ($BILLION); FIGURE 14. GLUCOSE MONITORING DEVICES MARKET FOR FLASH GLUCOSE MONITORING SYSTEMS, BY COUNTRY, 2024 - 2033 ($BILLION); FIGURE 15. GLUCOSE MONITORING DEVICES MARKET FOR SMARTPHONE APPS AND WEARABLES, BY COUNTRY, 2024 - 2033 ($BILLION); FIGURE 16. GLOBAL GLUCOSE MONITORING DEVICES MARKET SEGMENTATION, BY PATIENT TYPE; FIGURE 17. GLUCOSE MONITORING DEVICES MARKET FOR TYPE 1 DIABETES, BY COUNTRY, 2024 - 2033 ($BILLION); FIGURE 18. GLUCOSE MONITORING DEVICES MARKET FOR TYPE 2 DIABETES, BY COUNTRY, 2024 - 2033 ($BILLION); FIGURE 19. GLOBAL GLUCOSE MONITORING DEVICES MARKET SEGMENTATION, BY END USER; FIGURE 20. GLUCOSE MONITORING DEVICES MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY, 2024 - 2033 ($BILLION); FIGURE 21. GLUCOSE MONITORING DEVICES MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2024 - 2033 ($BILLION); FIGURE 22. GLUCOSE MONITORING DEVICES MARKET FOR OTHERS, BY COUNTRY, 2024 - 2033 ($BILLION); FIGURE 23. TOP WINNING STRATEGIES, BY YEAR, 2021-2023*; FIGURE 24. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2021-2023*; FIGURE 25. TOP WINNING STRATEGIES, BY COMPANY, 2021-2023*; FIGURE 26. PRODUCT MAPPING OF TOP 10 PLAYERS; FIGURE 27. COMPETITIVE DASHBOARD; FIGURE 28. COMPETITIVE HEATMAP: GLUCOSE MONITORING DEVICES MARKET; FIGURE 29. TOP PLAYER POSITIONING, 2023; FIGURE 30. MENARINI DIAGNOSTICS S.R.L.: NET SALES, 2021-2023 ($BILLION); FIGURE 31. MENARINI DIAGNOSTICS S.R.L.: REVENUE SHARE, BY SEGMENT, 2023 (%); FIGURE 32. MENARINI DIAGNOSTICS S.R.L.: REVENUE SHARE, BY REGION, 2023 (%); FIGURE 33. SENSEONICS, A.: NET SALES, 2021-2023 ($BILLION); FIGURE 34. SENSEONICS, A.: REVENUE SHARE, BY SEGMENT, 2023 (%); FIGURE 35. SENSEONICS, A.: REVENUE SHARE, BY REGION, 2023 (%); FIGURE 36. NOVO NORDISK A/S: NET SALES, 2021-2023 ($BILLION); FIGURE 37. NOVO NORDISK A/S: REVENUE SHARE, BY SEGMENT, 2023 (%); FIGURE 38. NOVO NORDISK A/S: REVENUE SHARE, BY REGION, 2023 (%); FIGURE 39. GLYSENS INCORPORATED: NET SALES, 2021-2023 ($BILLION); FIGURE 40. GLYSENS INCORPORATED: REVENUE SHARE, BY SEGMENT, 2023 (%); FIGURE 41. GLYSENS INCORPORATED: REVENUE SHARE, BY REGION, 2023 (%); FIGURE 42. JOHNSON AND JOHNSON: NET SALES, 2021-2023 ($BILLION); FIGURE 43. JOHNSON AND JOHNSON: REVENUE SHARE, BY SEGMENT, 2023 (%); FIGURE 44. JOHNSON AND JOHNSON: REVENUE SHARE, BY REGION, 2023 (%); FIGURE 45. DEXCOM, INC.: NET SALES, 2021-2023 ($BILLION); FIGURE 46. DEXCOM, INC.: REVENUE SHARE, BY SEGMENT, 2023 (%); FIGURE 47. DEXCOM, INC.: REVENUE SHARE, BY REGION, 2023 (%); FIGURE 48. MEDTRONIC PLC: NET SALES, 2021-2023 ($BILLION); FIGURE 49. MEDTRONIC PLC: REVENUE SHARE, BY SEGMENT, 2023 (%); FIGURE 50. MEDTRONIC PLC: REVENUE SHARE, BY REGION, 2023 (%); FIGURE 51. F. HOFFMAN-LA ROCHE LTD: NET SALES, 2021-2023 ($BILLION); FIGURE 52. F. HOFFMAN-LA ROCHE LTD: REVENUE SHARE, BY SEGMENT, 2023 (%); FIGURE 53. F. HOFFMAN-LA ROCHE LTD: REVENUE SHARE, BY REGION, 2023 (%); FIGURE 54. ABBOTT LABORATORIES: NET SALES, 2021-2023 ($BILLION); FIGURE 55. ABBOTT LABORATORIES: REVENUE SHARE, BY SEGMENT, 2023 (%); FIGURE 56. ABBOTT LABORATORIES: REVENUE SHARE, BY REGION, 2023 (%); FIGURE 57. B. BRAUN SE: NET SALES, 2021-2023 ($BILLION); FIGURE 58. B. BRAUN SE: REVENUE SHARE, BY SEGMENT, 2023 (%); FIGURE 59. B. BRAUN SE: REVENUE SHARE, BY REGION, 2023 (%)